October 11, 2019
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
|Re:||Titan Pharmaceuticals, Inc.|
Registration Statement on Form S-1, as amended (File No. 333-233722)
Ladies and Gentlemen:
As the underwriter of the proposed offering of Titan Pharmaceuticals, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 9:15 a.m., Eastern Time, on October 15, 2019, or as soon thereafter as is practicable.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
|Very truly yours,|
|Maxim Group LLC|
|By:||/s/ Clifford A. Teller|
|Name: Clifford A. Teller|
Title: Head of Investment Banking, Executive Managing Director